{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:36:26Z","timestamp":1794281786596,"version":"4.9.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"The Australian National Health and Medical Research Council Targeted Call for Research into Frailty in Hospital Care","award":["APP 1174447"],"award-info":[{"award-number":["APP 1174447"]}]},{"DOI":"10.13039\/501100008810","name":"NSW Ministry of Health","doi-asserted-by":"publisher","award":["eHealth NSW"],"award-info":[{"award-number":["eHealth NSW"]}],"id":[{"id":"10.13039\/501100008810","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008810","name":"NSW Ministry of Health","doi-asserted-by":"publisher","award":["Northern Sydney"],"award-info":[{"award-number":["Northern Sydney"]}],"id":[{"id":"10.13039\/501100008810","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008810","name":"NSW Ministry of Health","doi-asserted-by":"publisher","award":["Central Coast Local Health District ICT Departments"],"award-info":[{"award-number":["Central Coast Local Health District ICT Departments"]}],"id":[{"id":"10.13039\/501100008810","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s40266-023-01032-6","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T06:51:24Z","timestamp":1683701484000},"page":"633-642","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Impact of a Comprehensive Intervention Bundle Including the Drug Burden Index on Deprescribing Anticholinergic and Sedative Drugs in Older Acute Inpatients: A Non-randomised Controlled Before-and-After Pilot Study"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7876-6004","authenticated-orcid":false,"given":"Kenji","family":"Fujita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1796-3183","authenticated-orcid":false,"given":"Patrick","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7123-9583","authenticated-orcid":false,"given":"Nashwa","family":"Masnoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5272-9958","authenticated-orcid":false,"given":"Sarita","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9404-3401","authenticated-orcid":false,"given":"Danijela","family":"Gnjidic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5148-0188","authenticated-orcid":false,"given":"Christopher","family":"Etherton-Beer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1405-999X","authenticated-orcid":false,"given":"Emily","family":"Reeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parker","family":"Magin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Simon","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6674-995X","authenticated-orcid":false,"given":"Kenneth","family":"Rockwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0927-7295","authenticated-orcid":false,"given":"Lisa Kouladjian","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0565-3524","authenticated-orcid":false,"given":"Mouna","family":"Sawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1645-9126","authenticated-orcid":false,"given":"Melissa","family":"Baysari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5970-1501","authenticated-orcid":false,"given":"Sarah N.","family":"Hilmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,9]]},"reference":[{"issue":"2","key":"1032_CR1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5694\/mja14.00336","volume":"202","author":"L Parkinson","year":"2015","unstructured":"Parkinson L, Magin PJ, Thomson A, Byles JE, Caughey GE, Etherton-Beer C, et\u00a0al. Anticholinergic burden in older women: not seeing the wood for the trees? Med J Aust. 2015;202(2):91\u20134.","journal-title":"Med J Aust"},{"issue":"12","key":"1032_CR2","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1111\/jgs.16776","volume":"68","author":"I Malagaris","year":"2020","unstructured":"Malagaris I, Mehta HB, Li S, Goodwin JS. Decrease of anticholinergic drug use in nursing home residents in the United States, 2009 to 2017. J Am Geriatr Soc (JAGS). 2020;68(12):2797\u2013804.","journal-title":"J Am Geriatr Soc (JAGS)"},{"key":"1032_CR3","doi-asserted-by":"crossref","first-page":"204209862110125","DOI":"10.1177\/20420986211012592","volume":"12","author":"M Herrero-Zazo","year":"2021","unstructured":"Herrero-Zazo M, Berry R, Bines E, Bhattacharya D, Myint PK, Keevil VL. Anticholinergic burden in older adult inpatients: patterns from admission to discharge and associations with hospital outcomes. Ther Adv Drug Saf. 2021;12:20420986211012590.","journal-title":"Ther Adv Drug Saf."},{"issue":"1\/2","key":"1032_CR4","first-page":"45","volume":"41","author":"J Bell","year":"2012","unstructured":"Bell J, Mezrani C, Blacker N, LeBlanc T, Frank O, Alderman CP, et\u00a0al. Anticholinergic and sedative medicines: prescribing considerations for people with dementia. Aust Fam Physician. 2012;41(1\/2):45\u20139.","journal-title":"Aust Fam Physician"},{"issue":"1","key":"1032_CR5","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/clpt.2008.224","volume":"85","author":"S Hilmer","year":"2009","unstructured":"Hilmer S, Gnjidic D. The effects of polypharmacy in older adults. Clin Pharmacol Ther. 2009;85(1):86\u20138.","journal-title":"Clin Pharmacol Ther"},{"key":"1032_CR6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.mad.2019.111119","volume":"181","author":"SN Hilmer","year":"2019","unstructured":"Hilmer SN, Wu H, Zhang M. Biology of frailty: implications for clinical pharmacology and drug therapy in frail older people. Mech Ageing Dev. 2019;181:22\u20138.","journal-title":"Mech Ageing Dev"},{"issue":"6","key":"1032_CR7","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/jgs.15804","volume":"67","author":"E Reeve","year":"2019","unstructured":"Reeve E, Low L-F, Hilmer SN. Attitudes of older adults and caregivers in Australia toward deprescribing: ATTITUDES TOWARD DEPRESCRIBING. J Am Geriatr Soc (JAGS). 2019;67(6):1204\u201310.","journal-title":"J Am Geriatr Soc (JAGS)."},{"key":"1032_CR8","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.2147\/IJGM.S253177","volume":"14","author":"H Wu","year":"2021","unstructured":"Wu H, Kouladjian O\u2019Donnell L, Fujita K, Masnoon N, Hilmer SN. Deprescribing in the older patient: a narrative review of challenges and solutions. Int J Gen Med. 2021;14:3793\u2013807.","journal-title":"Int J Gen Med."},{"issue":"6","key":"1032_CR9","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/bcp.12732","volume":"80","author":"E Reeve","year":"2015","unstructured":"Reeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging definition of \u2018deprescribing\u2019 with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80(6):1254\u201368.","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"1032_CR10","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archinte.167.8.781","volume":"167","author":"SN Hilmer","year":"2007","unstructured":"Hilmer SN, Mager DE, Simonsick EM, Cao Y, Ling SM, Windham BG, et\u00a0al. A Drug Burden Index to define the functional burden of medications in older people. Arch Intern Med (1960). 2007;167(8):781\u20137.","journal-title":"Arch Intern Med (1960)"},{"key":"1032_CR11","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.2147\/CIA.S66660","volume":"9","author":"L Kouladjian","year":"2014","unstructured":"Kouladjian L, Gnjidic D, Chen TF, Mangoni AA, Hilmer SN. Drug Burden Index in older adults: theoretical and practical issues. Clin Interv Aging. 2014;9:1503\u201315.","journal-title":"Clin Interv Aging"},{"key":"1032_CR12","doi-asserted-by":"crossref","unstructured":"Hilmer SNMDP, Mager DEPP, Simonsick EMP, Ling SMMD, Windham BGMD, Harris TBMDMS, et\u00a0al. Drug burden index score and functional decline in older people. Am J Med. 2009;122(12):1142\u20139.e2.","DOI":"10.1016\/j.amjmed.2009.02.021"},{"issue":"1","key":"1032_CR13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2125.2009.03411.x","volume":"68","author":"D Gnjidic","year":"2009","unstructured":"Gnjidic D, Cumming RG, Le Couteur DG, Handelsman DJ, Naganathan V, Abernethy DR, et\u00a0al. Drug Burden Index and physical function in older Australian men. Br J Clin Pharmacol. 2009;68(1):97\u2013105.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"1032_CR14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/clpt.2011.258","volume":"91","author":"D Gnjidic","year":"2012","unstructured":"Gnjidic D, Hilmer SN, Blyth FM, Naganathan V, Cumming RG, Handelsman DJ, et\u00a0al. High-risk prescribing and incidence of frailty among older community-dwelling men. Clin Pharmacol Ther. 2012;91(3):521\u20138.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"1032_CR15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/JCP.0b013e3182487825","volume":"32","author":"D Gnjidic","year":"2012","unstructured":"Gnjidic D, Le Couteur DG, Naganathan V, Cumming RG, Creasey H, Waite LM, et\u00a0al. Effects of Drug Burden Index on cognitive function in older men. J Clin Psychopharmacol. 2012;32(2):273\u20137.","journal-title":"J Clin Psychopharmacol"},{"issue":"5","key":"1032_CR16","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1532-5415.2011.03386.x","volume":"59","author":"NM Wilson","year":"2011","unstructured":"Wilson NM, Hilmer SN, March LM, Cameron ID, Lord SR, Seibel MJ, et\u00a0al. Associations between Drug Burden Index and falls in older people in residential aged care. J Am Geriatr Soc (JAGS). 2011;59(5):875\u201380.","journal-title":"J Am Geriatr Soc (JAGS)."},{"key":"1032_CR17","doi-asserted-by":"crossref","first-page":"204209861983247","DOI":"10.1177\/2042098619832471","volume":"10","author":"L Kouladjian O'Donnell","year":"2019","unstructured":"Kouladjian O\u2019Donnell L, Gnjidic D, Chen TF, Hilmer SN. Integration of an electronic Drug Burden Index risk assessment tool into Home Medicines Reviews: deprescribing anticholinergic and sedative medications. Ther Adv Drug Saf. 2019;10:2042098619832471.","journal-title":"Ther Adv Drug Saf."},{"issue":"9","key":"1032_CR18","first-page":"CD008165","volume":"2018","author":"A Rankin","year":"2018","unstructured":"Rankin A, Cadogan CA, Patterson SM, Kerse N, Cardwell CR, Bradley MC, et\u00a0al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2018;2018(9):CD008165.","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"1032_CR19","first-page":"CD002894","volume":"2013","author":"F Gillaizeau","year":"2013","unstructured":"Gillaizeau F, Chan E, Trinquart L, Colombet I, Walton RT, R\u00e8ge-Walther M, et\u00a0al. Computerized advice on drug dosage to improve prescribing practice. Cochrane Database Syst Rev. 2013;2013(11):CD002894.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1032_CR20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12911-021-01484-z","volume":"21","author":"MT Baysari","year":"2021","unstructured":"Baysari MT, Duong MH, Hooper P, Stockey-Bridge M, Awad S, Zheng WY, et\u00a0al. Supporting deprescribing in hospitalised patients: formative usability testing of a computerised decision support tool. BMC Med Inform Decis Mak. 2021;21(1):116.","journal-title":"BMC Med Inform Decis Mak."},{"issue":"4","key":"1032_CR21","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.sapharm.2020.06.010","volume":"17","author":"M Sawan","year":"2021","unstructured":"Sawan M, O\u2019Donnell LK, Reeve E, Gnjidic D, Chen TF, Kelly PJ, et\u00a0al. The utility of a computerised clinical decision support system intervention in home medicines review: a mixed-methods process evaluation. Res Soc Adm Pharm. 2021;17(4):715\u201322.","journal-title":"Res Soc Adm Pharm"},{"issue":"3","key":"1032_CR22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/17512433.2020.1730812","volume":"13","author":"M Sawan","year":"2020","unstructured":"Sawan M, Reeve E, Turner J, Todd A, Steinman MA, Petrovic M, et\u00a0al. A systems approach to identifying the challenges of implementing deprescribing in older adults across different health-care settings and countries: a narrative review. Expert Rev Clin Pharmacol. 2020;13(3):233\u201345.","journal-title":"Expert Rev Clin Pharmacol."},{"issue":"2","key":"1032_CR23","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/bcp.15517","volume":"89","author":"N Masnoon","year":"2023","unstructured":"Masnoon N, Lo S, Hilmer S. A stewardship program to facilitate anticholinergic and sedative medication deprescribing using the drug burden index in electronic medical records. Br J Clin Pharmacol. 2023;89(2):687\u201398.","journal-title":"Br J Clin Pharmacol"},{"key":"1032_CR24","volume":"355","author":"SM Eldridge","year":"2016","unstructured":"Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, et\u00a0al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ. 2016;355: i5239.","journal-title":"BMJ"},{"issue":"5","key":"1032_CR25","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3109\/07853890.2011.573499","volume":"44","author":"D Gnjidic","year":"2012","unstructured":"Gnjidic D, Bell JS, Hilmer SN, L\u00f6nnroos E, Sulkava R, Hartikainen S. Drug Burden Index associated with function in community-dwelling older people in Finland: a cross-sectional study. Ann Med (Helsinki). 2012;44(5):458\u201367.","journal-title":"Ann Med (Helsinki)."},{"issue":"1","key":"1032_CR26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s40266-020-00820-8","volume":"38","author":"MH Duong","year":"2020","unstructured":"Duong MH, McLachlan AJ, Bennett AA, Jokanovic N, Le Couteur DG, Baysari MT, et\u00a0al. Iterative development of clinician guides to support deprescribing decisions and communication for older patients in hospital: a novel methodology. Drugs Aging. 2020;38(1):75\u201387.","journal-title":"Drugs Aging"},{"issue":"12","key":"1032_CR27","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-033303","volume":"9","author":"N Jokanovic","year":"2019","unstructured":"Jokanovic N, Aslani P, Carter S, Duong M, Gnjidic D, Jansen J, et\u00a0al. Development of consumer information leaflets for deprescribing in older hospital inpatients: a mixed-methods study. BMJ Open. 2019;9(12): e033303.","journal-title":"BMJ Open"},{"issue":"11","key":"1032_CR28","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.sapharm.2021.03.002","volume":"17","author":"B Ng","year":"2021","unstructured":"Ng B, Duong M, Lo S, Le Couteur D, Hilmer S. Deprescribing perceptions and practice reported by multidisciplinary hospital clinicians after, and by medical students before and after, viewing an e-learning module. Res Soc Adm Pharm. 2021;17(11):1997\u20132005.","journal-title":"Res Soc Adm Pharm"},{"key":"1032_CR29","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. Structure and principles: the WHO Anatomical Therapeutic Chemical (ATC) Classification System. 2018. https:\/\/www.whocc.no\/atc\/structure_and_principles\/. Accessed 10 Oct 2022."},{"issue":"5","key":"1032_CR30","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/aje\/kwp440","volume":"171","author":"GS Bieler","year":"2010","unstructured":"Bieler GS, Brown GG, Williams RL, Brogan DJ. Estimating model-adjusted risks, risk differences, and risk ratios from complex survey data. Am J Epidemiol. 2010;171(5):618\u201323.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"1032_CR31","first-page":"54","volume":"1","author":"B Efron","year":"1986","unstructured":"Efron B, Tibshirani R. Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Stat Sci. 1986;1(1):54\u201375.","journal-title":"Stat Sci"},{"issue":"7","key":"1032_CR32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0265368","volume":"17","author":"JA Grembi","year":"2022","unstructured":"Grembi JA, Rogawski McQuade ET. Introducing riskCommunicator: an R package to obtain interpretable effect estimates for public health. PLoS ONE. 2022;17(7): e0265368.","journal-title":"PLoS ONE"},{"issue":"1","key":"1032_CR33","first-page":"88","volume":"346","author":"PS Roshanov","year":"2013","unstructured":"Roshanov PS, Fernandes N, Wilczynski JM, Hemens BJ, You JJ, Handler SM, et\u00a0al. Features of effective computerised clinical decision support systems: meta-regression of 162 randomised trials. BMJ (Online). 2013;346(1):88\u2013657.","journal-title":"BMJ (Online)."},{"issue":"2","key":"1032_CR34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2165\/11531560-000000000-00000","volume":"27","author":"RL Castelino","year":"2010","unstructured":"Castelino RL, Hilmer SN, Bajorek BV, Nishtala P, Chen TF. Drug Burden Index and potentially inappropriate medications in community-dwelling older people: the impact of home medicines review. Drugs Aging. 2010;27(2):135\u201348.","journal-title":"Drugs Aging"},{"issue":"8","key":"1032_CR35","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2165\/11316440-000000000-00000","volume":"26","author":"PS Nishtala","year":"2009","unstructured":"Nishtala PS, Hilmer SN, McLachlan AJ, Hannan PJ, Chen TF. Impact of residential medication management reviews on drug burden index in aged-care homes: a retrospective analysis. Drugs Aging. 2009;26(8):677\u201386.","journal-title":"Drugs Aging"},{"issue":"11","key":"1032_CR36","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1345\/aph.1P310","volume":"44","author":"D Gnjidic","year":"2010","unstructured":"Gnjidic D, Couteur DGL, Abernethy DR, Hilmer SN. A pilot randomized clinical trial utilizing the drug burden index to reduce exposure to anticholinergic and sedative medications in older people. Ann Pharmacother. 2010;44(11):1725\u201332.","journal-title":"Ann Pharmacother"},{"issue":"8","key":"1032_CR37","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/imj.12203","volume":"43","author":"O Best","year":"2013","unstructured":"Best O, Gnjidic D, Hilmer SN, Naganathan V, McLachlan AJ. Investigating polypharmacy and drug burden index in hospitalised older people. Intern Med J. 2013;43(8):912\u20138.","journal-title":"Intern Med J"},{"issue":"5","key":"1032_CR38","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2165\/11631420-000000000-00000","volume":"29","author":"E L\u00f6nnroos","year":"2012","unstructured":"L\u00f6nnroos E, Gnjidic D, Hilmer SN, Bell JS, Kautiainen H, Sulkava R, et\u00a0al. Drug Burden Index and hospitalization among community-dwelling older people. Drugs Aging. 2012;29(5):395\u2013404.","journal-title":"Drugs Aging"},{"issue":"10","key":"1032_CR39","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1177\/0091270011421489","volume":"52","author":"E Lowry","year":"2012","unstructured":"Lowry E, Woodman RJ, Soiza RL, Hilmer SN, Mangoni AA. Drug Burden Index, physical function, and adverse outcomes in older hospitalized patients. J Clin Pharmacol. 2012;52(10):1584\u201391.","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"1032_CR40","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/jgs.12632","volume":"62","author":"M Kashyap","year":"2014","unstructured":"Kashyap M, Belleville S, Mulsant BH, Hilmer SN, Paquette A, Tu LM, et\u00a0al. Methodological challenges in determining longitudinal associations between anticholinergic drug use and incident cognitive decline. J Am Geriatr Soc (JAGS). 2014;62(2):336\u201341.","journal-title":"J Am Geriatr Soc (JAGS)."},{"issue":"11","key":"1032_CR41","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s40266-013-0111-y","volume":"30","author":"SW Narayan","year":"2013","unstructured":"Narayan SW, Hilmer SN, Horsburgh S, Nishtala PS. Anticholinergic component of the Drug Burden Index and the anticholinergic drug scale as measures of anticholinergic exposure in older people in New Zealand: a population-level study. Drugs Aging. 2013;30(11):927\u201334.","journal-title":"Drugs Aging"},{"issue":"7","key":"1032_CR42","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/pds.3624","volume":"23","author":"PS Nishtala","year":"2014","unstructured":"Nishtala PS, Narayan SW, Wang T, Hilmer SN. Associations of drug burden index with falls, general practitioner visits, and mortality in older people. Pharmacoepidemiol Drug Saf. 2014;23(7):753\u20138.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"1032_CR43","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/bcp.13792","volume":"85","author":"S Lalic","year":"2019","unstructured":"Lalic S, Ilom\u00e4ki J, Bell JS, Korhonen MJ, Gisev N. Prevalence and incidence of prescription opioid analgesic use in Australia. Br J Clin Pharmacol. 2019;85(1):202\u201315.","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"1032_CR44","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1111\/pme.12820","volume":"16","author":"S Holliday","year":"2015","unstructured":"Holliday S, Morgan S, Tapley A, Dunlop A, Henderson K, van Driel M, et\u00a0al. The pattern of opioid management by Australian general practice trainees. Pain Med (Malden, Mass). 2015;16(9):1720\u201331.","journal-title":"Pain Med (Malden, Mass)."},{"issue":"2","key":"1032_CR45","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/bmjqs-2020-010881","volume":"30","author":"AV Langford","year":"2021","unstructured":"Langford AV, Gnjidic D, Lin C-WC, Bero L, Penm J, Blyth FM, et\u00a0al. Challenges of opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines: a qualitative analysis. BMJ Qual Saf. 2021;30(2):133\u201340.","journal-title":"BMJ Qual Saf."},{"issue":"1","key":"1032_CR46","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1748-5908-6-92","volume":"6","author":"PS Roshanov","year":"2011","unstructured":"Roshanov PS, Misra S, Gerstein HC, Garg AX, Sebaldt RJ, Mackay JA, et\u00a0al. Computerized clinical decision support systems for chronic disease management: a decision-maker-researcher partnership systematic review. Implement Sci. 2011;6(1):92.","journal-title":"Implement Sci"},{"key":"1032_CR47","first-page":"m3216","volume":"370","author":"JL Kwan","year":"2020","unstructured":"Kwan JL, Lo L, Ferguson J, Goldberg H, Diaz-Martinez JP, Tomlinson G, et\u00a0al. Computerised clinical decision support systems and absolute improvements in care: meta-analysis of controlled clinical trials. BMJ (Online). 2020;370:m3216.","journal-title":"BMJ (Online)."},{"issue":"11","key":"1032_CR48","doi-asserted-by":"crossref","first-page":"e15385","DOI":"10.2196\/15385","volume":"21","author":"L Monteiro","year":"2019","unstructured":"Monteiro L, Maricoto T, Solha I, Ribeiro-Vaz I, Martins C, Monteiro-Soares M. Reducing potentially inappropriate prescriptions for older patients using computerized decision support tools: systematic review. J Med Internet Res. 2019;21(11):e15385.","journal-title":"J Med Internet Res"},{"issue":"6","key":"1032_CR49","doi-asserted-by":"crossref","first-page":"283","DOI":"10.5694\/mja2.51686","volume":"217","author":"IA Scott","year":"2022","unstructured":"Scott IA, Reeve E, Hilmer SN. Establishing the worth of deprescribing inappropriate medications: are we there yet? Med J Aust. 2022;217(6):283\u20136.","journal-title":"Med J Aust."},{"issue":"3","key":"1032_CR50","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jamainternmed.2021.7429","volume":"182","author":"EG McDonald","year":"2022","unstructured":"McDonald EG, Wu PE, Rashidi B, Wilson MG, Bortolussi-Courval \u00c9, Atique A, et\u00a0al. The MedSafer study\u2014electronic decision support for deprescribing in hospitalized older adults: a cluster randomized clinical trial. JAMA Intern Med. 2022;182(3):265\u201373.","journal-title":"JAMA Intern Med"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-023-01032-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-023-01032-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-023-01032-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T11:45:56Z","timestamp":1687866356000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-023-01032-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,9]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["1032"],"URL":"https:\/\/doi.org\/10.1007\/s40266-023-01032-6","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,9]]},"assertion":[{"value":"16 April 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open Access funding enabled and organized by CAUL and its Member Institutions. This study was supported by the Australian National Health and Medical Research Council Targeted Call for Research into Frailty in Hospital Care (APP 1174447).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"ER has received grants from the US National Institutes of Health, Australian Association of Gerontology (paid to employing institution) and royalties from UpToDate for writing a chapter on deprescribing. JSB has received grant funding or consulting funds from the NHMRC, Medical Research Future Fund, Victorian Government Department of Health and Human Services, Dementia Australia Research Foundation, Yulgilbar Foundation, Aged Care Quality and Safety Commission, Dementia Centre for Research Collaboration, Pharmaceutical Society of Australia, Society of Hospital Pharmacists of Australia, GlaxoSmithKline Supported Studies Programme, Amgen, and several aged care provider organisations unrelated to this work. All grants and consulting funds were paid to the employing institution. KR has asserted copyright of the Clinical Frailty Scale through Dalhousie University\u2019s Industry, Liaison, and Innovation Office. Use is free for education, research, and not-for-profit healthcare. Users agree not to change or commercialize the scale. In addition to academic and hospital appointments, KR is co-founder of Ardea Outcomes, which (as DGI Clinical) in the last 3\u00a0years has had contracts with pharma and device manufacturers (Danone, Hollister, INmune, Novartis, Takeda) on individualized outcome measurement. In 2020 he attended an advisory board meeting with Nutricia on dementia, and chaired a Scientific Workshop & Technical Review Panel on frailty for the Singapore National Research Foundation. Otherwise any personal fees are for invited guest lectures, rounds and academic symposia, received directly from event organizers, for presentations on frailty. KR is Associate Director of the Canadian Consortium on Neurodegenerataion in Aging, itself funded by the Canadian Institutes for Health Research, the Alzheimer Society of Canada and several other charities. SH developed and continues to lead an active research program on the Drug Burden Index. The Goal-directed Medication review Electronic Decision Support System (G-MEDSS), which includes a Drug Burden Index calculator, was developed by LKO under the supervision of SH, and is under consideration for commercialisation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Ethics approval was obtained from the Northern Sydney Local Health District Human Research Ethics\nCommittee (2019\/PID09249). A waiver of consent was granted for the extraction and use of the data from the electronic medical record as only non-identifiable data will be extracted.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"For the electronic Medical Record data extracts for this study period, the research team requested a waiver of consent in view of the large sample size.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The data are not publicly available due to privacy or ethical restrictions.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"The analytic code used to support the findings in this study is available from the corresponding author upon reasonable request.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"KF had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Conception and design: KF, NM, SL and SH. Acquisition, analysis, or interpretation of data: all authors. Drafting of the manuscript: KF. Critical revision of the manuscript for important intellectual content: all authors. Statistical analysis: KF. Obtained funding: SH. Supervision: SH. All authors read and approved the final manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}}]}}